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Abstract: Background: The pathological heart contractions, called arrhythmias, especially ventricular
fibrillation (VF), are a prominent feature of many cardiovascular diseases leading to sudden cardiac
death. The present investigation evaluates the effect of electrically stimulated VF on cardiac functions
related to autophagy and apoptotic mechanisms in isolated working rat hearts. Methods: Each
group of hearts was subjected to 0 (Control), 1, 3, or 10 min of spacing-induced VF, followed by
120 min of recovery period and evaluated for cardiac functions, including aortic flow (AF), coronary
flow (CF), cardiac output (CO), stroke volume (SV), and heart rate (HR). Hearts were also evaluated
for VF effects on infarcted zone magnitude and Western blot analysis was conducted on heart
tissue for expression of the apoptotic biomarker cleaved-caspase-3 and the autophagy proteins:
p62, P-mTOR/mTOR, LC3BII/LC3BI ratio, and Atg5-12 complexes. Results: Data revealed that VF
induced degradation in AF, CF, CO, and SV, which prominently included-variable post-VF capacity
for recovery of normal heart rhythm; increased extent of infarcted heart tissue; altered expression of
cleaved-caspase-3 suggesting potential for VF-mediated amplification of apoptosis. VF influence on
expression of p62, LC3BII/LC3BI, and Atg5-12 proteins was complex, possibly due to differential
effects of VF-induced expression on proteins comprising the autophagic program. Conclusions:
VF was observed to cause time-dependent changes in autophagy processes, which with additional
analysis under ongoing investigations, likely to yield novel therapeutic targets for the prevention of
VF and sudden cardiac death.
Keywords: ventricular fibrillation; apoptosis and autophagy; cell deaths
1. Introduction
Several pathological processes to cardiovascular tissue occur as a result of sudden restoration of
blood flow and cardiac function to tissues, and such an event may result in characteristic deleterious
effects and symptoms that include impairment of physiological functions. These outcomes are
due to oxidation of myocardial membrane lipids, perturbed ion homeostasis, and reactive oxygen
species [1–4], which lead to various cell deaths, including necrosis, apoptosis, and autophagy.
Support for this mechanistic model is provided by an observation that tissue damage and resulting
arrhythmias may be limited by pharmacological interventions diminishing their contribution to
the arrhythmic component of cardiac failure [5–9]. Previously, we have provided evidence of the
above processes as major underlying contributors to the pathophysiology of cardiac arrhythmias,
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particularly ventricular fibrillation (VF) [10,11]. Arrhythmias are a major cause of mortality in patients
afflicted with cardiovascular disease, or who have sustained cardiac injury sufficient to trigger these
phenomena [12,13], particularly those, in which persistent angina pectoris is a major symptom [14] and
may also be triggered by thrombolytic therapy, saphenous vein bypass grafting, release of coronary
spasm, and angioplasty [15]. Specific cellular events resulting in arrhythmias remain an open area for
investigation. Evidence indicates that cell membrane damage in cardiomyocytes results in the loss of
stable compartmentalization and transmembrane flux Ca2+, K+, Mg2+, and Na+ [16] with consequent
derangement of coordinated signaling to contractile elements of the myocardium, which leads to
ventricular fibrillation [11]. A major question that remains substantially unanswered is the extent
to which arrhythmia-associated pathophysiological changes to cardiovascular cells affect adaptive
processes that influence likelihood of recovery, versus death or debilitation following an arrhythmic
event. The present investigation addresses this issue by examination of electrically-induced VF on
cardiac function, magnitude of infarct zone extent, and expression of proteins that are clinical and/or
objective laboratory biomarkers for normal, versus disrupted heart function, necrosis, apoptosis, and
autophagy. It has previously been demonstrated that alterations in the principle cardiac functions,
including aortic flow (AF), coronary flow (CF), cardiac output (CO), stroke volume (SV), and heart rate
(HR) correlate with occurrence of arrhythmias in ways that clearly demonstrate common underlying
regulatory processes for both cardiac functions and arrhythmogenesis [17–19]. Nevertheless, it is
presently unknown whether various pathologic processes, which result in disruption of physiological
heart function and contributing cellular processes, such as apoptosis and autophagy, may be promoted
by the occurrence of arrhythmias. The major hypothesis of the present investigation is that the
occurrence of VF, which is one of the most clinically significant arrhythmic disorders leading to sudden
cardiac death, directly influences apoptotic and autophagic processes and signal transductions to an
extent that arrhythmias may act as major inducers of alterations in basic cellular, tissue, and organ
processes that underlie myocardial diseases.
2. Results
2.1. Effects of Pacing Induced Ventricular Fibrillation on Cardiac Recovery
The time-dependent effects of electrically-induced VF, perfusion and post-fibrillation recovery
intervals, on cardiac function in isolated working hearts are shown in Figure 1. As shown in Figure 1A.
AF was significantly reduced relative to the time-matched control values for hearts subjected to 10 min
of electrically-induced VF followed by 30, 60, and 120 min of post-VF recovery (p = 0.0175). Interestingly,
the average CF magnitudes (Figure 1B), in hearts subjected to 10 min of electrical fibrillation induction,
were significantly elevated relative to the control values following 60 min and 120 min of recovery,
respectively (p = 0.0149). Outcomes of cardiac output (CO) assessment shown in Figure 1C. indicates
a significantly reduced CO magnitude after a 1, 3, and 10 min period of VF followed by 30, 60, and
120 min of aerobic perfusion at each time point, respectively, (p = 0.0432). A reduction in SV values
after 10 min of VF followed by 120 min of aerobic perfusion (Figure 1D) was observed. No substantial
VF stimulation time-dependent effects were observed for either stroke volume Figure 1E. and heart
rate Figure 1F. relative to the time-matched control values at the corresponding time points.
2.2. Induced Ventricular Fibrillation Effects on the Infarcted Zone Magnitude
As it can be seen in Figure 2, no significant alteration in infarct volume was observed in hearts
undertaken for 1 and 3 min of pacing induced VF followed by 120 min of aerobic perfusion, in
comparison with hearts that received no electrically induced VF (control). Nevertheless, the average
infarcted size magnitude in hearts subjected to 10 min of VF stimulation was approximately 10-fold
higher compared to the control (no electrically induced VF) group (*** p < 0.001).
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Figure 1. Effects of electrically induced ventricular fibrillation (VF) and post-fibrillation recovery on 
cardiac function in isolated working heart preparation. Isolated working hearts taken from 
ketamine/xylazine-anesthetized Sprague-Dawley rats and segregated into test groups of 6 hearts per 
group were subjected to 0 (Control), 1, 3, and 10 min periods of electrically-induced VF (20 Hz, 1200 
beats/min), respectively. Each heart was then perfused with oxygenated Krebs-Henseleit bicarbonate 
buffer, and then allowed post-fibrillation recovery periods for 30, 60, and 120 min. Cardiac function 
was registered following each electrical VF induction and recovery period, including aortic flow (A); 
coronary flow (B); cardiac output (C); stroke volume changing (D); stroke volume (E); and heart rate 
(F). Results are shown as average values from each group of rat hearts ± SEM. n = 6 in each group, * p 
< 0.05 in comparison with the time-matched control values. 
2.2. Induced Ventricular Fibrillation Effects on the Infarcted Zone Magnitude 
As it can be seen in Figure 2, no significant alteration in infarct volume was observed in hearts 
undertaken for 1 and 3 min of pacing induced VF followed by 120 min of aerobic perfusion, in 
comparison with hearts that received no electrically induced VF (control). Nevertheless, the average 
infarcted size magnitude in hearts subjected to 10 min of VF stimulation was approximately 10-fold 
higher compared to the control (no electrically induced VF) group (*** p < 0.001). 
Figure 1. Effects of electrically induced ventricular fibrillation (VF) and post-fibrillation recovery
on cardiac function in isolated working heart preparation. Isolated working hearts taken from
ketamine/xylazine-anesthetized Sprague-Dawley rats and segregated into test groups of 6 hearts
per group were subjected to 0 (Control), 1, 3, and 10 min periods of electrically-induced VF (20 Hz,
1200 beats/min), respectively. Each heart was then perfused with oxygenated Krebs-Henseleit
bicarbonate buffer, and then allowed post-fibrillation recovery periods for 30, 60, and 120 min. Cardiac
function was registered following ach electrical VF inducti n and r cov ry p riod, including aortic
flow (A); coronary flow (B); cardiac output (C); strok volume changi g (D); stroke volume (E); and
heart rate (F). Results are shown as average values from each group of rat hearts ± SEM. n = 6 in each
group, * p < 0.05 in comparison with the time-matched control values.
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Figure 1. Effects of electrically induced ventricular fibrillation (VF) and post-fibrillation recovery on 
cardiac function in isolated working heart preparation. Isolated working hearts taken from 
ketamine/xylazine-anesthetized Sprague-Dawley rats and segregated into test groups of 6 hearts per 
group were subjected to 0 (Control), 1, 3, and 10 min periods of electrically-induced VF (20 Hz, 1200 
beats/min), respectively. Each heart was then perfused with oxygenated Krebs-Henseleit bicarbonate 
buffer, and then allowed post-fibrillation recovery periods for 30, 60, and 120 min. Cardiac function 
was registered following each electrical VF induction and recovery period, including aortic flow (A); 
coronary flow (B); cardiac output (C); stroke volume changing (D); stroke volume (E); and heart rate 
(F). Results are shown as average values from each group of rat hearts ± SEM. n = 6 in each group, * p 
< 0.05 in comparison with the time-match d control values. 
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Figure 2. Effects of electrically induced ventricular fibrillation on infarcted size. The time-dependent
effects of electrically induced VF duration (1, 3, and 10 min) followed by 120 min of perfusion on infarcted
zone extent in isolated working hearts are shown. Hearts taken from ketamine/xylazine-anesthetized
Sprague-Dawley rats and segregated into test groups of 6 hearts per group, were subjected to 0, (Control),
1, 3, and 10 min periods of electrically-induced VF (20 Hz, 1200 beats/min), respectively, followed by
120 min of perfusion. Staining, to demonstrate infarcted areas of heart tissue, was accomplished with
triphenyl tetrazolium chloride (TTC) solution in phosphate buffer. The percentages of heart damage
were assessed in 2–3 mm thick sections transversely sliced from the apico-basal axis into 2–3 mm thick
sections and analyzed using ImageJ software. Infarcted areas were measured by computerized planimetry
software and infarct magnitude was determined as percentage ratio of the infarcted zone to the total
area in each heart (percentage of pixels). Results are shown as average values from each group of rat
hearts ± SEM, and in comparison, with the control value. n = 6 in each group, *** p < 0.001.
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2.3. Induced Fibrillation on Caspase-3 Expression and TUNEL Positivity
Figure 3A. shows that relative to hearts subjected to no VF (control), and hearts subjected to 1 min
of VF expressed approximately 1.5× the quantity of cleaved-caspase-3 (* p < 0.05); and approximately
double the quantity of this protein after 3 min of VF (** p < 0.01); but with no significant difference
from the control hearts after 10 min of VF period followed by 120 min of aerobic perfusion. In line
with the caspase-3 expression, hearts subjected to 1 min and 3 min of VF followed by 120 min of
perfusion exhibited significant TUNEL positivity (Figure 3B). The most intense TUNEL positivity
was observed in hearts undertaken to 3 min of VF followed by 120 min of post-fibrillated perfusion
(Figure 3B). The numeric values of TUNEL positive nuclei are depicted in Figure 3C, showing that
TUNEL positivity was significantly increased in all three groups (*** p < 0.001) in comparison with the
control value.
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Figure 3. Western blot analysis: Effects of electrically induced fibrillation followed by aerobic 
perfusion on heart tissue expression of cleaved-caspase-3. Cleaved caspase-3 expression (A), 
representative TUNEL positivity (B), and percentage of TUNEL positive nuclei (visualized by a Zeiss 
AxioScope A1 microscope, EC Plan-Neo fluar 40×/0.75 M27 objective lens with HBO100 illuminator 
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Figure 3. Western blot analysis: Effects of electrically induced fibrillation followed by aerobic perfusion
on heart tissue expression of cleaved-caspase-3. Cleaved caspase-3 expression (A), representative
TUNEL positivity (B), and percentage of TUNEL positive nuclei (visualized by a Zeiss AxioScope
A1 microscope, EC Plan-Neo fluar 40×/0.75 M27 objective lens with HBO100 illuminator and Zeiss
AxioCam ICm1 camera (Zeiss, Jena, Germany) (C) are depicted. n = 8 in each group, mean ± SEM,
comparisons were made to the fibrillation-free control group. * p < 0.05, ** p < 0.01, and *** p < 0.01.
Figure 4A shows p62 in hearts subjected to 1, 3, and 10 min VF stimulation periods followed
by 120 min perfusion and expressed by approximately 1/3 (** p < 0.01), 1/2 (*** p < 0.001), and
2/3 (** p < 0.001) less of this protein, respectively. Expression levels of P-mTOR/mTOR ratio were
determined as a function of VF stimulation periods and displayed in Figure 4B. The ratio of
P-mTOR/mTOR showed a gradual increase with the extended duration of electrical VF. It is also
shown in Figure 4B. that relative to the unstimulated control group, no significant difference for the
average ratio of P-mTOR/mTOR ratio was observed in hearts subjected to 1 min of electrical VF.
This value was approximately 1/4 higher in hearts subjected to 3 min of VF period (* p < 0.05) and
further increased in hearts subjected to 10 min of VF (* p < 0.05). The time-dependent effect of VF
on the expression of LC3BII/LC3BI protein ratio by tissue from isolated perfused hearts is shown in
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Figure 4C. The results revealed that relative to the unstimulated Control group, hearts subjected to
1, 3, and 10 min of VF periods showed no significant changes in this protein expression, although
a gradual decrease was registered. The average expression levels of Atg5-12 complex proteins as
a function of VF stimulation is shown in Figure 4D. Relative to the control group receiving no VF
stimulation, no significant differences in average expression of this protein complex were observed
for hearts subjected to 1 min and 10 min periods of VF. However, interestingly, the average Atg5-12
expression levels in hearts subjected to 3 min of stimulated VF were approximately increased by 25%
(p < 0.05) in comparison with the non-fibrillated control group.
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Figure 4. Western blot analysis: Effects of electrically induced fibrillation on heart tissue expression of
p62 (A), mTOR-phosphorylated, and mTOR (mTOR) (B) ratio, LC3BII/LC3BI ratio (C) and Atg5-12
complex (D) proteins. The time-dependent (0, 1, 3, and 10 min) effects of electrically induced VF
followed by 120 min perfusion on expressions of selected proteins in isolated working hearts are shown.
Hearts were taken from rats and segregated into test groups of 6 hearts per group, and were subjected
to 0 (Control), 1, 3, and 10 min periods of electrically-induced VF (20 Hz, 1200 beats = min), respectively,
followed by 120 min of aerobic perfusion. Western blot analysis to assess expression of each target
protein was conducted. Signals for each protein band were measured using Bio-Rad Clarity Western
ECL Substrate and optical density of the bands was evaluated with the ChemiDoc Touch Imaging
System. Protein expressions for each sample of heart tissue was calculated using Bio-Rad Image Lab
5.2 software. Results are shown as average values from each group of 6 hearts, mean ± SEM. * p < 0.05,
** p < 0.01, and *** p < 0.001 compared to the Control (non-fibrillated group).
3. Discussion
3.1. Pacing-Induced VF on Infarct Size and Caspase-3 Activation
The effect of ventricular arrhythmias on cardiac function and different pathways of cell death
were the main focus in the present investigation. The duration of electrical stimuli induced ventricular
fibrillation could be contributed to the depression of cardiac function including aortic flow, coronary
flow, and stroke volume changes. Decreased cardiac function was accompanied by enlarged infarcted
volume. Compared to the Control hearts subjected to no VF stimuli, the approximately 10-fold
greater infarcted zone extent was detected in hearts subjected to 10 min duration of VF, which may
be accounted for the capacity of electrically-induced VF to promote pathway-mediated oxidative
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damage in heart tissue as described earlier [18]. The longest duration of electrically-induced VF was
detrimental to the development of infarcted myocardium as TTC staining discriminates between
the living and dead tissues [20,21]. The known mechanisms by which infarcted zone expansion is
triggered and augmented, strongly suggests degradation of metabolite compartmentalization within
cardiomyocytes and other cardiovascular cells, resulting in both arrhythmogenesis and derangement of
cardiac function [22,23]. An enhanced number of TUNEL positive cells were observed in all electrically
fibrillated hearts. Interestingly, it was the highest following 3 min period of electrical fibrillation.
These observations were in line with the cleaved caspase-3 results indicating the highest cleaved
caspase-3 expression in hearts undertaken to 3 min of ventricular fibrillation. Caspase-3 activation is an
early event in the apoptotic cell death cascade, and very high activity of this enzyme may trigger disease
through excessive apoptosis in the intact myocardium [24]. Thus, the presence of the cleaved molecule
could be a major biomarker for cardiovascular pathologies, prominently in stroke and myocardial
infarction, leukemia [25], and death of neurons in Alzheimer’s disease [26]. Authors have previously
investigated various processes and demonstrated how amplification of endogenous cytoprotection by
induction of heme oxygenases-1 (HO-1) using sour cherry seed-derived HO-1 inducers, and/or beta
carotene dramatically limits the extent of infarcted zones in cardiac tissue [27,28].
3.2. VF Influence on Apoptosis- and Autophagy-Associated Proteins: Western Blot Studies
Western blot data in Figure 3. shows VF effects on expression of apoptosis, and it reveals that
the duration of VF significantly influenced the level of cleaved caspase, at which cardiomyocytes
experienced during these processes in the model used under in vitro conditions. Figure 3A. shows
significant VF-dependent increases in tissue production of cleaved (activated) caspase-3 (cysteinyl
aspartate-specific protease-3) at 1 and 3 min of VF, relative to the control value. The ubiquitin-binding
p62 sequestosome 1 protein (SQSTM1) accumulates when autophagy is inhibited, thus, the significantly
decreased p62 expression in isolated working heart tissue with 1–10 min of VF relative to the control
value, indicates that autophagy is induced by VF, as shown in Figure 4A. Outcomes of analysis
for phosphorylated mammalian target of rapamycin (P-mTOR), which is the activated form of this
enzyme on this cell growth in response to nutritional cues [29], and its ratio to the inactive form
(P-mTOR/mTOR) is shown in Figure 4B. Here, the significantly increased P-mTOR/mTOR ratio
occurring with longer VF periods is consistent with the expected result of exposure of cells to elevated
autophagic processes. It is known that oxidative damage to a cell’s genome induces increased high
levels of mTOR activation, and cell cycle arrest (an anticancer mechanism), which subsequently also
causes formation of senescent cell phenotypes that are hypersecretory for inflammatory cytokines,
an effect that causes inflammatory tissue damage—constitution a major underlying mechanism of
age-related physical deterioration [30]. Authors of this report have previously demonstrated that the
pathophysiology of these processes is promoted by cardiac arrhythmias and counteracted by induction
of autophagy [31,32]. These findings further reinforce observations shown in Figure 4A. demonstrating
VF-associated decrease in cardiac tissue expression of the p62 protein. p62 acts as a sensor molecule
recognizing toxic cellular waste and is subsequently sequestered into autophagosomes resulting in its
rapid clearance in the cell, thus decreasing its signal activity [33].
3.3. Usefulness and Limitations on Use of LC3BII/LC3BI and Atg5-12 Complex Proteins as Autophagy
Indicators in Fibrillated Hearts
Outcomes of the final set of experiments conducted in this investigation are shown in Figure 4C,D.
Results in Figure 4C show a gradually decreased but not significant in LC3BII/LC3BI expression in all
groups compared to the control value, which suggests that VF induction suppresses the autophagy
processes. Thus, this report provides preliminary evidence for the validity of this hypothesis [32].
The possibility that hearts, at least within the constraints of the present model, may exhibit characteristic
fluctuations in VF-associated autophagic responses, is further reinforced by the results of assay for
Atg5-12 complex proteins shown in Figure 4D. Initially, with the context of results shown in Figure 4C,
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the time course of LC3BII/LC3BI expression suggests a VF-induced decrease in autophagy, followed
by restoration to the levels exhibited by the control group. In addition, data in Figure 4A, shows a
progressive decrease in the p62 expression signal during 1–10 min of VF, suggesting that autophagy is
promoted. These outcomes notwithstanding, the results shown in Figure 4D should be interpreted
with an understanding of the biological role of the Atg5-12 complex proteins. These proteins interact in
fairly complex ways in autophagosome assembly, with expression, function, and degradation of each
component occurring according to a tightly coordinated program over the timeline, in which a cell or
tissue is undergoing an autophagic response [34]. Thus, it is likely that the highly prooxidant tissue
environment of the myocardium experiencing electrically-stimulated VF would experience significant
derangement in the expression and degradation kinetics of individual Atg proteins, rendering the
Atg5-12 signal unsuitable as a single and simple metric for autophagy. Data in Figure 4C,D may
support this possibility by the existence of fluctuation in expression of each of the proteins studied.
Here, their presence in the tissue is clearly related to the effect and role of VF on autophagy, but might
be more relevant to VF-induced influence on particular protein components than on the predominant
occurrence of autophagy in VF-treated heart tissue. However, it has to be noted that in the present
study autophagic flux was not studied.
3.4. Conclusions
This investigation has revealed several features of heart tissue response to electrically-stimulated
VF that may prove enormously useful in ongoing exploration of arrythmogenesis, with particularly
valuable insight into autophagy-related pathophysiology. A major positive outcome, as this has
improved understanding of both the usefulness and limitations of the electrically-stimulated VF
model of the isolated working rodent heart, in which the authors have relied on extensively as an
investigative tool over several decades of cardiovascular research. It is here acknowledged that
although some of its aspects may depart from being precisely analogous to in vivo conditions, the
tissue environment and resulting arrhythmogenic consequences provided a close enough parallel to
the failing vertebrate heart as to allow clinically relevant conclusions to be drawn. Further, results of
this report which demonstrated variable post-VF capacity for recovery of normal rhythm from heart to
heart, underscored the caution that cardiologists may need to exercise in tailoring therapy to individual
patients. Observations of VF effects on cardiac infarction expanded the scope of potential use for
inducers of endogenous defenses including apoptosis and autophagy as a countermeasure to this effect;
and demonstration of VF effects on biomarkers for apoptosis, and autophagy-associated proteins open
novel directions in approaches to intervention in arrhythmogenic influences by which each process
may be manipulated to address a wide range of disease states, extending on cardiovascular medicine.
4. Materials and Methods
4.1. Animals
Male Sprague-Dawley rats weighing 370–400 g (Charles River International, Inc., Sulzfeld,
Germany) were used for all experiments in the present study. The animals were housed at room
temperature (approximately 25 ◦C), with lighting set to alternating dark and light periods of 12 h.
The rats were maintained on normal rodent chow and tap water ad libitum. All animals received
humane care, in compliance with the “Principles of Laboratory Animal Care” according to the National
Society for Medical Research and the Guide for the Care and Use of Laboratory Animals, formulated by
the National Academy of Sciences, and published by the National Institute of Health (NIH Publication
No. 86-23, revised 1985). All protocols involving animal use were approved by the Committee of
Animal Research, University of Debrecen, Hungary (3/2012/DEMAB, 21-03-2012).
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4.2. Chemical Reagents
All chemicals and buffer solutions were obtained from Sigma-Aldrich Ltd. (Schnelldorf, Germany).
The perfusion medium was a modified Krebs-Henseleit bicarbonate buffer composed of NaCl
118 mmol, KCl 5.8 mmol, CaCl2 1.8 mmol, NaHCO3 25 mmol, NaH2PO4 0.36 mmol, MgSO4 1.2 mmol,
and glucose 11.1 mmol, dissolved in redistilled water.
4.3. Isolated Working Heart Preparation and Perfusion Protocol
Rats were anesthetized with intraperitoneal injection of ketamine (50 mg/kg) and xylazine
(10 mg/kg), and heparin (1000 U/kg) was then injected intravenously through the dorsal penile
vein. After thoracotomy, hearts were excised, and placed into ice-cold perfusion buffer, with a
composition described above (chemical reagents) and filtered through a 0.65 µmol porosity filter to
remove any particulate contaminants. Perfusion of hearts was conducted using a 5 min washout
period in Langendorff mode via the cannulated aorta, and then the left atrium was also cannulated.
The perfusion fluid then passed to the left ventricle, from which it was spontaneously ejected through
the aortic cannula against a pressure equivalent to 100 cm of water [18].
4.4. Test Groups
Hearts taken from the animals were segregated into test groups and subjected to 0 (Control), 1, 3,
and 10 min of VF periods, respectively. Electrical fibrillation was carried out by 20 Hz (1200 beats/min)
for 1, 3, and 10 min, respectively, using 5 V square-wave pulses of 2 ms duration. The active
lead was attached to the apex of the heart and the ground lead was attached to the aortic cannula.
These conditions suppressed the sinus node activity and resulted in VF consisting of an irregular
undulating baseline on the ECG. Following the termination of electrical fibrillation, hearts were allowed
post-fibrillation recovery period for 120 min. At the end of the 120 min of post-fibrillation recovery
period, the expression or repression of the autophagic and apoptotic proteins were determined. Aortic
flow, coronary flow, cardiac output, stroke volume, and heart rate were monitored. The aortic flow and
coronary flow rate were measured by timed collection of the coronary perfusate that dripped directly
from each heart. The cardiac output was determined as the sum of aortic flow and coronary flow in
milliliters per min, from which stroke volume was additionally calculated.
4.5. Infarction Zone Magnitude in VF-Treated Isolated Hearts
Triphenyl-tetrazolium chloride (TTC) staining was used to determine infarcted areas. For these
experiments, hearts were subjected to 0 (Control), 1, 3, and 10 min of VF followed by 120 min of
post-fibrillated perfusion. A total of 100 mL of 1% TTC solution in phosphate buffer (Na2HPO4,
88.05 mmol, NaH2PO4 1.8 mmol) was heated to 37 ◦C and administered directly via the side arm of
the aortic cannula. TTC-stained viable myocardium was deep red, while potentially infarcted areas
remained pale, allowing clear demonstration and measurement of infarction magnitude. Hearts were
stored at −80 ◦C for a subsequent analysis and then sliced transversely to the apico-basal axis into
2–3 mm thick sections, weighted, blotted dry, and placed in between microscope slides, then scanned
at 600 dpi on a Hewlett-Packard Scanjet single pass flatbed scanner (Hewlett-Packard, Palo Alto,
CA, USA). Using ImageJ software, each image was subjected to equivalent degrees of background
subtraction, brightness, and contrast enhancement for improved clarity and distinctness. Infarct area
(pale areas, white pixels) of each slice were traced and the respective areas were calculated by pixel
density analysis. Infarcted areas and total area were measured by computerized planimetry software.
Infarct size was expressed as a percentage ratio of the infarcted zone to the total area in each heart
(percentage of pixels).
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4.6. Westerns Blot Analysis
Protein expression levels for cleaved-caspase-3, p62, mTOR, phosphorylated P-mTOR,
LC3BII/LC3BI, and Atg5-12 complex proteins were evaluated using Western immunoblotting. Proteins
were isolated from myocardial tissue with homogenizing buffer (25 mM Tris-HCl, pH 8, 25 mmol
NaCl, 1 mmol Na-Orthovanadate, 10 mmol NaF, 10 mmol Na-Pyrophosphate, 10 nmol Okadiac acid,
0.5 mmol EDTA, 1 mmol PMSF, 1× protease inhibitor cocktail) using a polytron homogenisator on
ice. Next, after 10 min centrifugation, 2000 rpm at 4 ◦C supernatants were transferred to fresh tubes
and centrifuged for 20 min at 10000 rpm and 4 ◦C. The supernatants were used as cytosolic fractions.
Protein concentration was measured by BCA Protein Assay Kit (Thermo Scientific, Waltham, MA,
USA). Proteins were separated using 4–20% Mini-PROTEAN®TGX Stain-Free™ Protein Gels then
transferred onto polyvinylidene fluoride (PVDF) membranes. Non-specific binding was blocked using
non-fat milk in Tris-buffered saline with 1% Tween20 for 30 min at room temperature. After washing
with TBS-T the membranes were incubated overnight at 4 ◦C with primary antibodies against LC3B
(1:1000), Atg5 (1:500), Atg12 (1:500), p62 (1:1000), cleaved-caspase3 (1:1000), mTOR (1:2000) and
P-mTOR (1:2000). After 3 washes the membranes were incubated with secondary antibody for 1.5 h at
room temperature and signal intensities for each protein band were detected using Clarity Western
ECL Substrate (Bio-Rad, Hercules, CA, USA). The optical density of bands was measured using the
ChemiDoc Touch Imaging System and protein levels determined with the Bio-Rad Image Lab 5.2
software (Bio-Rad). The levels of the investigated proteins were normalized against the total protein
loaded on the gels. The protein expression was quantified by the ratio of (band volume)/(total protein
volume). Thus, this method eliminates the need for housekeeping proteins [35,36].
4.7. Fluorescens Cell Death Detection
To detect apoptosis, we used the terminal deoxynucleotidyl transferase (TdT) nick end labelling
test by the In Situ Cell Death Detection Kit, TMR (fluorescein-labeled cell markers) red (Roche,
Mannheim, Germany). Apoptosis can be detected by labeling the free 3′-OH termini with modified
nucleotides in an enzymatic reaction. The enzyme terminal deoxynucleotidyl transferase (TdT)
catalyzes the template-independent polymerization of deoxyribonucleotides to the 3′-end of single-
and double-stranded DNA. Harvested hearts tissue were fixed in 4% formalin for 24 h at 4 ◦C,
embedded in paraffin, and cut into 4.5 µm thick sections. All tissue sections were deparaffined in
xylene and acetone then rehydrated in 70% ethanol and water. The sections were boiled in citrate
buffer pH 6.0 for 12 min, then cooled at room temperature for 20 min, thereafter, washed two times for
5 min in phosphate-buffered saline (PBS pH 7.4). Finally, sections were incubated with TdT (terminal
deoxynucleotidyl transferase) in a humidified box, at 37 ◦C for 1 h. After washing, to identify nuclei,
we used DAPI (4′,6-diamidino-2-phenylindole), which emits blue fluorescence upon binding to AT
regions of DNA (Thermo Fisher Scientific, Waltham, MA, USA). The slides were then washed with
PBS, after being air-dried, and subsequently covered with mounting medium and glass slide covers.
Moviol solution was used as a mounting medium. Fluorescence microscopic images were obtained
by a Zeiss AxioScope A1 microscope, EC Plan-Neo fluar 40×/0.75 M27 objective lens with HBO100
illuminator and Zeiss AxioCam ICm1 camera (Zeiss, Jena, Germany). After merging the blue and
red channels, purple spots were associated with apoptotic nuclei, while blue spots were identified as
non-apoptotic nuclei (ZEN 2012 software, Zeiss). Apoptosis was quantified by ratio of TdT-positive
nuclei/total nuclei in each section.
4.8. Data Analysis and Statistics
All data are presented as average magnitudes of each outcome in a group ± standard error of
the mean (SEM). Normality of data sets were verified with the D’Agostino-Pearson omnibus test.
A Student’s t-test was used to determine differences between two sets of data. More than two data
sets were compared with one-way ANOVA followed by Tukey post-testing. Difference of means was
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considered significant at * p < 0.05, ** p < 0.01, and *** p < 0.001. Statistical analysis was carried out
with GraphPad Prism 6.07. (GraphPad Software Inc., San Diego, CA, USA).
5. Limitation of the Study
It has been noted that direct measurement of the oxidative stress marker was not assessed.
However, previously it has been shown that pacing-induced VF induces free radical formation [18].
In addition, the isolated heart used in the present investigation is a blood free experimental model,
thus, no circulating hormones and transmitters are present, which influence the response of cardiac
tissue to different stimuli [27]. Finally, it should be also noted that a direct test for electrical instability
following VF episodes was not carried out [37].
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